Skip to Content

Get Your FREE Consultation

Martin & Jones, PLLC logo

“Thank you for your concern of my well-being every time I spoke with you. It always meant so much. I hear nothing but awful stories of dealing with attorneys and their offices, but I have had nothing but positive experience. You have many special ways of working with people in need of help. Words can never express the way your support has been so helpful. I pray you will continue to help others. I wish you all the best.”

Print PDF

Let a North Carolina Elmiron Lawyer Help if You’ve Suffered Vision Problems After Use of the Medication 

Martin & Jones is evaluating claims that long term use of Elmiron causes maculopathy and/or other serious vision problems.  Elmiron is a drug prescribed to treat bladder pain caused by interstitial cystitis (“IC”), suffered primarily by women.  Elmiron is the only FDA approved drug to treat the condition, more commonly referred to as “bladder pain syndrome,” which includes symptoms of chronic bladder pain, urinary frequency, and painful sexual intercourse. If you believe you have a dangerous product claim, we encourage you to contact a North Carolina Elmiron attorney at our firm. 

Research Studying Maculopathy and Other Dangers of Elmiron  

In 2018, researchers found a link between Elmiron and pigmentary maculopathy, a unique ocular injury that can result in permanent vision loss and blindness.  Medical experts are suggesting that people who have taken Elmiron for six months or more undergo ophthalmic evaluation with retinal imaging.  Potential symptoms of pigmentary maculopathy include:

  • Difficulty of eyes adjusting to dim lighting or darkness
  • Difficulty reading
  • Dark spot in the field of vision
  • Blurred vision
  • Seeing muted, less vibrant colors

Prior to June 16, 2020, the product labeling for Elmiron did not include a warning for pigmentary maculopathy or any form of maculopathy or retinopathy.  The label was changed in June 2020 to read: “ Pigmentary changes in the retina, reported in the literature as pigmentary maculopathy, have been identified with long-term use of ELMIRON.  Although most of the cases occurred after three years of use or longer, cases have been seen with a shorter duration of use.  While the etiology is unclear, cumulative dose appears to be a risk factor.”  

In December 2020, an MDL was established for the federal cases and centralizing the cases in New Jersey before the Honorable Brian Martinotti.  The plaintiffs allege that the manufacturers never provided any warnings of maculopathy or retinopathy associated with the drug or warned patients to obtain regular eye exams to monitor vision in until the label was updated in June 2020.

Visit One of Our Many Office Locations to Speak with an Elmiron Attorney. 

If you have taken Elmiron for six months or longer and have suffered an injury, please contact Martin & Jones for a free evaluation with an Elmiron lawyer. Our offices are conveniently located in Raleigh, Durham, and Wilmington, and we are skilled in harmful medication cases.  

Need A Personal Injury Lawyer?

Helping injured people is what we do. Contact us today for a free consultation to find out how we can help you.

Hear it from our clients

No Win, No Fee

Review Us

Contact Our North Carolina Personal Injury Law Firm

for a Consultation for Your Accident or Medical Malpractice Claim

Call us at 800-662-1234
No Win, No Fee

The law firm you choose makes a difference. If you are the victim of an accident or an illness that someone else caused, the North Carolina personal injury law firm of Martin & Jones has the depth of experience, skills and sensitivity to make your road to recovery as smooth as possible. Whether you have experience with the legal system or have never hired a medical malpractice or personal injury lawyer before, our attorneys and staff will do our best to answer your questions, provide clear advice and prepare you and your family for what to expect. If you would like more information or to meet with one of our attorneys, please fill out the form below or call us at 800.662.1234.